These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 29976440)
1. The death of low-dose oral theophylline for COPD? The Lancet Respiratory Medicine Lancet Respir Med; 2018 Jul; 6(7):479. PubMed ID: 29976440 [No Abstract] [Full Text] [Related]
2. [Development of theophylline in treatment of asthma and chronic obstructive pulmonary disease]. Xu YJ Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Jun; 26(3):319-22. PubMed ID: 15266839 [TBL] [Abstract][Full Text] [Related]
3. [When beta-mimetic and anticholinergic agents fail in COPD. More air with theophylline]. MMW Fortschr Med; 2004 Apr; 146(18):57. PubMed ID: 15366477 [No Abstract] [Full Text] [Related]
4. Mortality risk in patients receiving drug regimens with theophylline for chronic obstructive pulmonary disease. Lee TA; Schumock GT; Bartle B; Pickard AS Pharmacotherapy; 2009 Sep; 29(9):1039-53. PubMed ID: 19698009 [TBL] [Abstract][Full Text] [Related]
5. Management of chronic obstructive pulmonary disease. Statement about theophyllines is misleading. O'Driscoll BR BMJ; 2003 Apr; 326(7393):821; author reply 821. PubMed ID: 12689985 [No Abstract] [Full Text] [Related]
7. [COPD and pneumonia therapy in the elderly. What is different in aging lungs]. Stiefelhagen P MMW Fortschr Med; 2008 Oct; 150(43):12-4. PubMed ID: 19031577 [No Abstract] [Full Text] [Related]
8. Is There room for Theophylline in COPD? Toledo-Pons N; CosÃo BG Arch Bronconeumol; 2017 Oct; 53(10):539-540. PubMed ID: 28645434 [No Abstract] [Full Text] [Related]
9. Comparative study of the efficacy and safety of theophylline and doxofylline in patients with bronchial asthma and chronic obstructive pulmonary disease. Lal D; Manocha S; Ray A; Vijayan VK; Kumar R J Basic Clin Physiol Pharmacol; 2015 Sep; 26(5):443-51. PubMed ID: 25894641 [TBL] [Abstract][Full Text] [Related]
10. Theophylline in chronic obstructive pulmonary disease: new horizons. Barnes PJ Proc Am Thorac Soc; 2005; 2(4):334-9; discussion 340-1. PubMed ID: 16267358 [TBL] [Abstract][Full Text] [Related]
11. [Effect of sustained release of theophylline on pulmonary physiologic function in elderly patients with chronic obstructive pulmonary disease]. Teramoto S Nihon Ronen Igakkai Zasshi; 2002 Jul; 39(4):414-8. PubMed ID: 12187806 [TBL] [Abstract][Full Text] [Related]
12. Doxofylline is not just another theophylline! Matera MG; Page C; Cazzola M Int J Chron Obstruct Pulmon Dis; 2017; 12():3487-3493. PubMed ID: 29255355 [TBL] [Abstract][Full Text] [Related]
13. Chronic Use of Theophylline and Mortality in Chronic Obstructive Pulmonary Disease: A Meta-analysis. Horita N; Miyazawa N; Kojima R; Inoue M; Ishigatsubo Y; Kaneko T Arch Bronconeumol; 2016 May; 52(5):233-8. PubMed ID: 26612542 [TBL] [Abstract][Full Text] [Related]
14. A prospective survey on safety of sustained-release theophylline in treatment of asthma and COPD. Makino S; Adachi M; Ohta K; Kihara N; Nakajima S; Nishima S; Fukuda T; Miyamoto T; ; Allergol Int; 2006 Dec; 55(4):395-402. PubMed ID: 17130682 [TBL] [Abstract][Full Text] [Related]
15. A comparison between inhaled salmeterol and theophylline in the short-term treatment of stable chronic obstructive pulmonary disease. Broseghini C; Testi R; Polese G; Tosatto R; Rossi A Pulm Pharmacol Ther; 2005; 18(2):103-8. PubMed ID: 15649852 [TBL] [Abstract][Full Text] [Related]
16. Theophylline: taking it to a new level. Messerschmidt K S D J Med; 1996 Jun; 49(6):201-2. PubMed ID: 8693341 [No Abstract] [Full Text] [Related]
18. Positive benefits of theophylline in a randomized, double-blind, parallel-group, placebo-controlled study of low-dose, slow-release theophylline in the treatment of COPD for 1 year. Zhou Y; Wang X; Zeng X; Qiu R; Xie J; Liu S; Zheng J; Zhong N; Ran P Respirology; 2006 Sep; 11(5):603-10. PubMed ID: 16916334 [TBL] [Abstract][Full Text] [Related]
19. [COPD treatment by drugs]. Nafti S Rev Mal Respir; 2006 Sep; 23(4 Pt 2):10S58-10S60. PubMed ID: 17127967 [No Abstract] [Full Text] [Related]
20. Long-term treatment with theophylline reduces neutrophils, interleukin-8 and tumor necrosis factor-alpha in the sputum of patients with chronic obstructive pulmonary disease. Iiboshi H; Ashitani J; Katoh S; Sano A; Matsumoto N; Mukae H; Nakazato M Pulm Pharmacol Ther; 2007; 20(1):46-51. PubMed ID: 16413994 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]